Novartis AG
NVS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001114448
No open-market purchases or sales by Novartis AG insiders were filed in the last 90 days; 1,626 institutions reported holding it in 13F filings for Q2 2026, worth $21.3B in total; Maverick Capital is the only superinvestor holding it.
Other share classesNVSEF
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +43 vs. previous quarter
- 1,626
- 13F valueReported value at the end of Q2 2026
- $21.3B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Superinvestors holding NVS, Q2 2026
1 superinvestor reports holding Novartis AG on Form 13F. Percentages are the stock's share of each portfolio.
Latest insider trades
Open-market purchases and sales by Novartis AG insiders from Form 4, newest first.
No open-market purchases or sales by Novartis AG insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Novartis AG at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Fisher Asset Management, LLC | 15,523,378 | $2.43B | 0.72% | +1,637,629+11.8% | Added |
| Morgan Stanley | 8,726,827 | $1.37B | 0.07% | +199,790+2.3% | Added |
| Dimensional Fund Advisors LP | 8,117,586 | $1.27B | 0.23% | +7,470+0.1% | Added |
| Primecap Management Co | 6,592,124 | $1.03B | 0.61% | −975,230−12.9% | Reduced |
| Loomis Sayles & Co L P | 5,239,309 | $821.1M | 1.03% | −186,791−3.4% | Reduced |
| Bank of America Corp | 4,909,938 | $769.5M | 0.05% | −52,856−1.1% | Reduced |
| Franklin Resources Inc | 3,251,281 | $509.5M | 0.11% | −158,663−4.7% | Reduced |
| BlackRock, Inc. | 3,047,988 | $477.7M | 0.01% | +98,228+3.3% | Added |
| Goldman Sachs Group Inc | 2,980,168 | $467.1M | 0.05% | −3,545,603−54.3% | Reduced |
| Northern Trust Corp | 2,792,745 | $437.7M | 0.05% | +6,517+0.2% | Added |